Login / Signup

Broad-Spectrum Antifungal Agents: Fluorinated Aryl- and Heteroaryl-Substituted Hydrazones.

Nishad Thamban ChandrikaEmily K DennisKatelyn R BrubakerStefan KwiatkowskiDavid S WattSylvie Garneau-Tsodikova
Published in: ChemMedChem (2020)
Fluorinated aryl- and heteroaryl-substituted monohydrazones displayed excellent broad-spectrum activity against various fungal strains, including a panel of clinically relevant Candida auris strains relative to a control antifungal agent, voriconazole (VRC). These monohydrazones displayed less hemolysis of murine red blood cells than that of VRC at the same concentrations, possessed fungicidal activity in a time-kill study, and exhibited no mammalian cell cytotoxicity. In addition, these monohydrazones prevented the formation of biofilms that otherwise block antibiotic effectiveness and did not trigger the development of resistance when exposed to C. auris AR Bank # 0390 over 15 passages.
Keyphrases
  • candida albicans
  • red blood cell
  • escherichia coli
  • molecular docking
  • biofilm formation
  • randomized controlled trial
  • single cell
  • cell therapy
  • cystic fibrosis